Literature DB >> 12235103

Cancer therapy and renal injury.

Robert W Schrier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12235103      PMCID： PMC151139          DOI： 10.1172/JCI16568

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  19 in total

Review 1.  Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.

Authors:  Stephan Segerer; Peter J Nelson; Detlef Schlöndorff
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

2.  Apoptosis induced by cisplatin nephrotoxic injury.

Authors:  A H Lau
Journal:  Kidney Int       Date:  1999-10       Impact factor: 10.612

3.  Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide.

Authors:  Christopher A Davis; Harry S Nick; Anupam Agarwal
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

4.  Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury.

Authors:  J Deng; Y Kohda; H Chiao; Y Wang; X Hu; S M Hewitt; T Miyaji; P McLeroy; B Nibhanupudy; S Li; R A Star
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

5.  Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase.

Authors:  M Knotek; B Rogachev; W Wang; T Ecder; V Melnikov; P E Gengaro; M Esson; C L Edelstein; C A Dinarello; R W Schrier
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

6.  Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody.

Authors:  K J Kelly; S M Meehan; R B Colvin; W W Williams; J V Bonventre
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

7.  Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure.

Authors:  V Y Melnikov; T Ecder; G Fantuzzi; B Siegmund; M S Lucia; C A Dinarello; R W Schrier; C L Edelstein
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

8.  Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells.

Authors:  G P Kaushal; V Kaushal; X Hong; S V Shah
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

9.  Renal dysfunction in allogeneic hematopoietic cell transplantation.

Authors:  Chirag R Parikh; Peter A McSweeney; Didem Korular; Tevfik Ecder; Aicha Merouani; Jeremy Taylor; Vicki Slat-Vasquez; Elizabeth J Shpall; Roy B Jones; Scott I Bearman; Robert W Schrier
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

Review 10.  Chemotactic factors and renal inflammation.

Authors:  B H Rovin; L T Phan
Journal:  Am J Kidney Dis       Date:  1998-06       Impact factor: 8.860
View more
  36 in total

1.  Combination therapy with cisplatin and anti-4-1BB: synergistic anticancer effects and amelioration of cisplatin-induced nephrotoxicity.

Authors:  Young H Kim; Beom K Choi; Kwang H Kim; Sang W Kang; Byoung S Kwon
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

2.  Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury.

Authors:  Motoko Yanagita; Tomohiko Okuda; Shuichiro Endo; Mari Tanaka; Katsu Takahashi; Fumihiro Sugiyama; Satoshi Kunita; Satoru Takahashi; Atsushi Fukatsu; Masashi Yanagisawa; Toru Kita; Takeshi Sakurai
Journal:  J Clin Invest       Date:  2005-12-08       Impact factor: 14.808

3.  Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.

Authors:  Partha Mukhopadhyay; Béla Horváth; Malek Kechrid; Galin Tanchian; Mohanraj Rajesh; Amarjit S Naura; A Hamid Boulares; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2011-08-17       Impact factor: 7.376

4.  IL-33 exacerbates acute kidney injury.

Authors:  Ali Akcay; Quocan Nguyen; Zhibin He; Kultigin Turkmen; Dong Won Lee; Ana Andres Hernando; Christopher Altmann; Aysun Toker; Arijana Pacic; Danica Galesic Ljubanovic; Alkesh Jani; Sarah Faubel; Charles L Edelstein
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

5.  CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.

Authors:  Partha Mukhopadhyay; Hao Pan; Mohanraj Rajesh; Sándor Bátkai; Vivek Patel; Judith Harvey-White; Bani Mukhopadhyay; György Haskó; Bin Gao; Ken Mackie; Pál Pacher
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  A Role for Tubular Necroptosis in Cisplatin-Induced AKI.

Authors:  Yanfang Xu; Huabin Ma; Jing Shao; Jianfeng Wu; Linying Zhou; Zhirong Zhang; Yuze Wang; Zhe Huang; Junming Ren; Suhuan Liu; Xiangmei Chen; Jiahuai Han
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

7.  Monophosphoryl lipid A pretreatment suppresses sepsis- and LPS-induced proinflammatory cytokine production in the medullary thick ascending limb.

Authors:  Bruns A Watts; Esther Tamayo; Edward R Sherwood; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-18

8.  Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy.

Authors:  Vinayak Sudhir Jamdade; Nitin A Mundhe; Parveen Kumar; Venkatesh Tadla; Mangala Lahkar
Journal:  Pathol Oncol Res       Date:  2015-10-06       Impact factor: 3.201

9.  Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.

Authors:  Hao Pan; Zhoujun Shen; Partha Mukhopadhyay; Hua Wang; Pal Pacher; Xuebin Qin; Bin Gao
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

10.  Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Hao Pan; Vivek Patel; Bani Mukhopadhyay; Sándor Bátkai; Bin Gao; György Haskó; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2009-12-04       Impact factor: 7.376
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.